Sökning: "Cardiovascular events."
Visar resultat 16 - 20 av 364 avhandlingar innehållade orden Cardiovascular events..
16. Cardiovascular outcomes and extra-articular manifestations in patients with spondyloarthritis
Sammanfattning : Background: Spondyloarthritis (SpA) is a cluster of rheumatic diseases with similar clinical features, including association with extra-articular manifestations such as anterior uveitis (AU), inflammatory bowel disease (IBD) and psoriasis. Ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated SpA (uSpA) are the major subtypes of SpA. LÄS MER
17. Microvesicle signaling in cardiovascular biology under normal and pathobiological conditions
Sammanfattning : Cardiovascular disease (CVD) is one of the leading causes of death worldwide. Atherosclerosis, a chronic pathology directly related to the circulatory system, develops due to an interplay between several molecular events. Atherosclerotic plaque build-up can lead to a reduction in arterial blood flow and finally, myocardial infarction (MI). LÄS MER
18. IL-25 and B cells in atherosclerosis
Sammanfattning : Atherosclerosis is a chronic inflammatory disease of medium and large vessels of the body which is mainly characterized by the formation of lipid rich plaques within the arterial tissue. It is the most common cause of cardiovascular disease leading to clinical manifestations of coronary artery and cerebrovascular disease. LÄS MER
19. Cardiovascular Side Effects of Radiotherapy in Breast Cancer
Sammanfattning : The aim of the thesis was to study cardiovascular side effects of radiotherapy (RT) in breast cancer (BC).In a study base of 25,171 women with BC diagnosed 1970-2000, we found a statistically significant 12% increase of stroke, compared to the stroke incidence in the background population. LÄS MER
20. Adherence to lipid-lowering medications and cardiovascular disease prevention in type 2 diabetes mellitus
Sammanfattning : Background and aims: Globally, cardiovascular disease (CVD) is the major cause of death among patients with type 2 diabetes mellitus (T2DM). Improved control of LDL cholesterol with lipid-lowering medications and patients’ adherence to such medications have been shown associate with lower risk of CV events and mortality among T2DM patients. LÄS MER